DAX23.591 -0,9%Est505.720 -1,1%MSCI World4.343 -0,1%Top 10 Crypto8,7500 -1,5%Nas22.388 -1,6%Bitcoin58.470 -0,3%Euro1,1619 ±0,0%Öl92,69 +9,9%Gold5.171 +1,7%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
freenet A0Z2ZZ AIXTRON A0WMPJ E.ON ENAG99 Münchener Rückversicherungs-Gesellschaft 843002 Heidelberg Materials 604700 Tesla A1CX3T Vonovia A1ML7J BioNTech (ADRs) A2PSR2 NEL ASA A0B733 AMD (Advanced Micro Devices) 863186 RWE 703712 Airbus 938914 Rolls-Royce A1H81L TKMS thyssenkrupp Marine Systems TKMS00 Micron Technology 869020
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Iran-Krieg weitet sich aus: DAX geht schwach ins Wochenende -- US-Börsen tiefer -- Lufthansa auf Wachstumskurs -- US-Chipaktien, TeamViewer, Oracle, Rüstungsaktien, Marvell, DroneShield im Fokus
Top News
Februar 2026: Analysten sehen Potenzial bei Rheinmetall-Aktie Februar 2026: Analysten sehen Potenzial bei Rheinmetall-Aktie
Peter Schiff lässt Alarmglocken schrillen: Bitcoin jetzt verkaufen - Sturz auf 20.000 US-Dollar droht Peter Schiff lässt Alarmglocken schrillen: Bitcoin jetzt verkaufen - Sturz auf 20.000 US-Dollar droht
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Galapagos Aktie

Kaufen
Verkaufen
Galapagos Aktien-Sparplan
28,30 EUR -0,46 EUR -1,60 %
BMN
28,20 EUR -1,34 EUR -4,54 %
GVIE
finanzen.net zero
Galapagos jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.1,90 Mrd. EUR

KGV5,75Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA0EAT9

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINBE0003818359

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolGLPGF

Galapagos Aktien News

DatumMeistgelesen
GlobeNewswireGalapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
GlobeNewswireGalapagos Creates New Subscription Right Plan
GlobeNewswireGalapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101
Wer­bungGalapagos-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
GlobeNewswireGalapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes
GlobeNewswireGalapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
GlobeNewswireGalapagos Announces Executive Leadership Updates
GlobeNewswireGalapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025
GlobeNewswireGalapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting
GlobeNewswireGalapagos to Present at Upcoming Investor Conferences
GlobeNewswireGalapagos receives transparency notification and 13D filing from Tang Capital
GlobeNewswireGalapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update
GlobeNewswireGalapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
GlobeNewswireGalapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswireGalapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
GlobeNewswireGalapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024
GlobeNewswireGalapagos Reports Third Quarter 2024 Financial Results and Provides Business Update
GlobeNewswireGalapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
GlobeNewswireGalapagos receives transparency notification from EcoR1 Capital
GlobeNewswireGalapagos receives transparency notification from EcoR1 Capital
GlobeNewswireGalapagos receives transparency notification from FMR LLC
GlobeNewswireGalapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma
GlobeNewswireGalapagos receives transparency notification from FMR LLC
PR NewswireBridGene Biosciences Expands Strategic Collaboration with Galapagos to Develop Selective Oral SMARCA2 PROTAC in Precision Oncology
GlobeNewswireGalapagos reports half-year 2024 financial results and provides second quarter business update
GlobeNewswireGalapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
GlobeNewswireGalapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future so
GlobeNewswireGalapagos creates new subscription right plans
GlobeNewswireGalapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
GlobeNewswireGalapagos reports first quarter 2024 financial results  
GlobeNewswireGalapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024
GlobeNewswireGalapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
GlobeNewswireGalapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
GlobeNewswireGalapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
GlobeNewswireGalapagos announces full year 2023 results and outlook for 2024
GlobeNewswireGalapagos presents at EBMT-EHA annual meeting 2024
GlobeNewswireGalapagos completes transaction to transfer Jyseleca® business to Alfasigma
GlobeNewswireGalapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.
PR NewswireBridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets
GlobeNewswireGalapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology
GlobeNewswireGalapagos signs agreement to transfer Jyseleca® business to Alfasigma

Galapagos News

Galapagos News: auf dieser Seite finden Sie alle Galapagos News und Nachrichten zur Galapagos Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Galapagos News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Galapagos News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.